Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Toxicologic Pathology
|
October 4, 2017
Role of Anatomic Pathology in Skeletal Evaluations: Applying INHAND Diagnostic Criteria
John L Vahle
Toxicologic Pathology
|
December 19, 2012
Introductory paper by Long et al on digital pathology validation
John L Vahle
Toxicologic Pathology
|
August 31, 2018
Immunogenicity and Immune Complex Disease in Preclinical Safety Studies
John L Vahle
Toxicologic Pathology
|
February 4, 2010
Carcinogenicity assessments: the debate continues
John L Vahle
Toxicologic Pathology
|
January 5, 2021
Inspiration and Exasperation: The Challenges of Inhaled Biologics
Peter Hall, John L Vahle, Karyn Colman
Toxicologic Pathology
|
December 22, 2007
Variations in animal populations over time and differences in diagnostic thresholds used can impact tumor incidence data
John L Vahle, Masahiko Sato, Gerald G Long
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 8, 2008
Lack of bone neoplasms and persistence of bone efficacy in cynomolgus macaques after long-term treatment with teriparatide [rhPTH(1-34)]
John L Vahle, Ulrich Zuehlke, Allen Schmidt, et al.
Toxicologic Pathology
|
February 8, 2011
Best practices for clinical pathology testing in carcinogenicity studies
Jamie K Young, Robert L Hall, Peter O'Brien, et al.
Toxicologic Pathology
|
June 19, 2004
Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose
John L Vahle, Gerald G Long, George Sandusky, et al.
International Journal of Toxicology
|
September 16, 2022
The Dog as a Second Species for Toxicology Testing Provides Value to Drug Development
Nancy Bower, William E Achanzar, Virginie Boulifard, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Toxicologic Pathology
|
October 4, 2017
Role of Anatomic Pathology in Skeletal Evaluations: Applying INHAND Diagnostic Criteria
John L Vahle
Toxicologic Pathology
|
December 19, 2012
Introductory paper by Long et al on digital pathology validation
John L Vahle
Toxicologic Pathology
|
August 31, 2018
Immunogenicity and Immune Complex Disease in Preclinical Safety Studies
John L Vahle
Toxicologic Pathology
|
February 4, 2010
Carcinogenicity assessments: the debate continues
John L Vahle
Toxicologic Pathology
|
January 5, 2021
Inspiration and Exasperation: The Challenges of Inhaled Biologics
Peter Hall, John L Vahle, Karyn Colman
Toxicologic Pathology
|
December 22, 2007
Variations in animal populations over time and differences in diagnostic thresholds used can impact tumor incidence data
John L Vahle, Masahiko Sato, Gerald G Long
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 8, 2008
Lack of bone neoplasms and persistence of bone efficacy in cynomolgus macaques after long-term treatment with teriparatide [rhPTH(1-34)]
John L Vahle, Ulrich Zuehlke, Allen Schmidt, et al.
Toxicologic Pathology
|
February 8, 2011
Best practices for clinical pathology testing in carcinogenicity studies
Jamie K Young, Robert L Hall, Peter O'Brien, et al.
Toxicologic Pathology
|
June 19, 2004
Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose
John L Vahle, Gerald G Long, George Sandusky, et al.
International Journal of Toxicology
|
September 16, 2022
The Dog as a Second Species for Toxicology Testing Provides Value to Drug Development
Nancy Bower, William E Achanzar, Virginie Boulifard, et al.
Page
of 3